| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,628,242 | 4,261,836 | 3,321,861 | 2,364,382 | 2,274,422 |
| Cost of Revenue
|
-2,585,936 | -2,426,460 | -2,117,467 | -1,670,130 | -1,551,369 |
|
Gross Profit
|
2,042,306 | 1,835,376 | 1,204,394 | 694,252 | 723,053 |
| Selling, General and Administrative Expenses
|
-422,781 | -388,118 | -338,957 | -235,604 | -230,121 |
|
Research and Development Expenses
|
-483,438 | -385,438 | -278,907 | -235,236 | -202,966 |
|
Other Income/Expense, Operating
|
-686 | -655 | 13 | 0 | 194 |
|
Operating Income/Expenses
|
-906,905 | -774,211 | -617,851 | -470,840 | -432,893 |
|
Total Operating Profit/Loss
|
1,135,401 | 1,061,165 | 586,543 | 223,412 | 290,160 |
| Total Net Finance Income/Expense
|
58,793 | 52,746 | -16,018 | -10,209 | -5,802 |
| Net Investment Income
|
111,153 | 90,279 | 67,684 | 60,141 | 75,760 |
| Irregular Income/Expenses
|
0 | 0 | 251 | 1,390 | 5,026 |
|
Other Income/Expense, Non-Operating
|
127,899 | 55,141 | 189,887 | 86,702 | 100,813 |
|
Non-Operating Income/Expenses, Total
|
297,845 | 198,166 | 241,804 | 138,024 | 175,797 |
|
Pretax Income
|
1,433,246 | 1,259,331 | 828,347 | 361,436 | 465,957 |
|
Provision for Income Tax
|
-238,570 | -215,391 | -131,278 | -43,064 | -62,457 |
|
Net Income from Continuing Operations
|
1,194,676 | 1,043,940 | 697,069 | 318,372 | 403,500 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,194,676 | 1,043,940 | 697,069 | 318,372 | 403,500 |
|
Non-Controlling/Minority Interests
|
949 | 135 | 469 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
1,195,625 | 1,044,075 | 697,538 | 318,372 | 403,500 |
|
Net Income Available to Common Stockholders
|
1,195,625 | 1,044,075 | 697,538 | 318,372 | 403,500 |
|
Diluted Net Income Available to Common Stockholders
|
1,195,625 | 1,044,075 | 697,538 | 318,372 | 403,500 |
| Basic EPS
|
12.89 | 11.29 | 8.47 | 3.90 | 4.99 |
| Diluted EPS
|
12.87 | 11.26 | 8.40 | 3.85 | 4.87 |
|
Basic Weighted Average Shares Outstanding
|
92,918.63 | 92,456.52 | 82,335.05 | 81,694.70 | 80,805.63 |
|
Diluted Weighted Average Shares Outstanding
|
93,145.18 | 92,701.98 | 83,018.73 | 82,752.92 | 82,788.59 |
|
EBIT
|
1,374,453 | 1,206,585 | 844,365 | 371,645 | 471,759 |
|
EBITDA
|
1,669,996 | 1,471,109 | 1,076,239 | 567,094 | 607,635 |
|
Normalized EBITDA
|
1,630,296 | 1,427,476 | 1,016,435 | 614,287 | 637,304 |
|
Normalized Income
|
1,161,584.22 | 1,007,769.81 | 646,742.86 | 359,942.10 | 429,192.17 |
|
Total Unusual Items
|
-39,700 | -43,633 | -59,804 | 47,193 | 29,669 |
12/31/2022 - 2/16/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade